Top Markets
#1 Palladium Network Palladium Network +27.90%
#2 Ankr Network Ankr Network +20.08%
#3 Fake World Assets Fake World Assets +8.58%
#4 Status Status +8.22%
#5 Pons Pons +6.97%
#6 Ribbita by Virtuals Ribbita by Virtuals +6.85%
#7 would would +6.62%
#8 WAX WAX +6.52%
#9 edgeX edgeX +6.10%
#10 Hive Hive +4.94%
Coin of the day
Palladium Network Palladium Network
Ustawienia
Język
POLSKI
Waluta
USD
Motyw
Nevro Corp. Nevro Corp.

Nevro Corp.

NVRO
Pozycja w akcjach #17833
Nevro Corp. is a medical technology firm that delivers solutions for... Nevro Corp. is a medical technology firm that delivers solutions for individuals experiencing persistent pain, serving markets both domestically in the United States and across the globe. The company's core business involves the development and market introduction of the Senza spinal cord stimulation (SCS) system, an advanced, clinically supported neuromodulation platform specifically engineered to alleviate chronic pain. This portfolio encompasses its newer generations, the Senza II and Senza Omnia systems. Additionally, Nevro offers its proprietary 10 kHz Therapy, providing neuromodulation approaches grounded in robust clinical evidence for effective chronic pain management. Its products are distributed through a diverse strategy, utilizing a dedicated direct sales team complemented by a network of specialized sales agents and independent distributors. Founded in 2006, Nevro Corp. maintains its corporate headquarters in Redwood City, California.
Cena akcji
$5.84
Ostatnia synchronizacja: 2025-04-02
Kapitalizacja rynkowa
$224.09M
Zmiana (1 dzień)
0.00%
Zmiana (1 rok)
0.00%
Kraj
US
Handel Nevro Corp. (NVRO)

Kategoria

Healthcare
Przychody dla Nevro Corp. (NVRO)
Przychody w Dec 2024 TTM: $408.52M
Według najnowszych raportów finansowych Nevro Corp., obecny przychód firmy (TTM) wynosi $408.52M. W roku 2023 firma osiągnęła przychód w wysokości $425.17M wzrost w porównaniu do przychodu z roku 2022, który wynosił $406.37M. Przychód to całkowita kwota dochodu generowana przez firmę ze sprzedaży towarów lub usług. W przeciwieństwie do zysku, nie są odliczane żadne koszty.
Historia przychodów firmy Nevro Corp. od 2012 do 2026
Przychody na koniec każdego roku
Rok Przychody Zmień
2026 (TTM) $408.52M 0.00%
2024 $408.52M -3.92%
2023 $425.17M 4.63%
2022 $406.37M 5.03%
2021 $386.91M 6.87%
2020 $362.05M -7.23%
2019 $390.26M 0.77%
2018 $387.29M 18.56%
2017 $326.67M 42.96%
2016 $228.50M 228.28%
2015 $69.61M 113.69%
2014 $32.57M 38.61%
2013 $23.50M 29.48%
2012 $18.15M 0.00%
Przychody podobnych firm lub konkurentów
Firma Przychody Różnica w przychodach Kraj
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
 $46.59B 11,303.41%
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
 $25.84B 6,224.57%
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
 $35.48B 8,586.03%
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
 $21.00B 5,039.55%
US
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
Edwards Lifesciences Corporation
EW.US
 $6.51B 1,494.13%
US